Matt Kaeberlein discusses rapamycin, biological clocks and longevity research
In this video description, Prof Matt Kaeberlein discusses mTOR biology, rapamycin, caloric restriction, biological clocks and limits of the hallmarks of aging framework; the video and transcript were not reviewed. [1]
Automatic summary · not editorially reviewed
The key findings
The description lists mTOR biology, rapamycin, caloric restriction, biological clocks and limits of the hallmarks of aging framework as discussion topics. [1]
Matt Kaeberlein is described as a University of Washington professor and Co-Director of the Dog Aging Project. [1]
The description mentions biological age testing but reports no results about it. [1]
The source at a glance
- Study type / format
- Video description of a conversation episode
- Population / context
- Prof Matt Kaeberlein and the topics named in the episode description
- Summary based on
- Creator description
- Original publication
- May 25, 2026
Topics listed for the Kaeberlein conversation
The description says the episode is a wide-ranging conversation with Prof Matt Kaeberlein about the current state and future of longevity science. It lists mTOR biology, rapamycin, caloric restriction, biological clocks, AI-driven discovery and the limitations of the hallmarks of aging framework. It also mentions supplement hype, biological age testing and large-scale unbiased discovery science. These are topics named in the description, not findings reported there.
Supporting source [1]
Kaeberlein’s roles and projects named in the description
The description identifies Matt Kaeberlein as a Professor at the University of Washington and Co-Director of the Dog Aging Project. It says his research focuses on biological mechanisms of aging and interventions to improve healthspan in humans and companion animals. It also names Ora Biomedical and the WormBot and Million Molecule Challenge among projects and topics discussed. No results from these projects are given in the description.
Supporting source [1]
Scope of this description-only explainer
This explainer relies only on the supplied video description. The video and transcript were not reviewed, so no statements, data or conclusions from the conversation itself can be confirmed here. The description names topics such as rapamycin trials in India and preventative longevity medicine but gives no details, numbers or outcomes. Mentions of biological clocks or biological age testing do not establish that any test works or predicts health outcomes.
Supporting source [1]
How to interpret this
Only the video description was supplied; the video and transcript were not reviewed. Topics are named without data, results or conclusions.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Longevity India · youtube.com · May 25, 2026